Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Archives of Psychiatry and Clinical Neuroscience

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s004060170053PMID 11407439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients.

  2000cited by this paper
• Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers

  1999cited by this paper
• The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes.

  1998cited by this paper
• Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man

  1995cited by this paper
• In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used.

  1995cited by this paper
• PCR detection of the TaqA RFLP at the DRD2 locus.

  1993cited by this paper
• Determination of bromperidol in serum by automated column-switching high-performance liquid chromatography.

  1989cited by this paper
• Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes.

  1986cited by this paper
• Statistical Power Analysis for the Behavioral Sciences

  1969influential reference

• Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics

  2024cites this paper
• Ethnic Differences in Antipsychotic Response: What Genetic Variation Does and Does Not Tell Us

  2023cites this paper
• Neuroimaging of Small Vessel Disease in Late-Life Depression.

  2019cites this paper
• Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia

  2018cites this paper
• In silico repurposing of antipsychotic drugs for Alzheimer’s disease

  2017cites this paper
• The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis

  2016cites this paper
• Genetic Variants of Neurotransmitter-Related Genes and miRNAs in Egyptian Autistic Patients

  2013cites this paper
• Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol

  2013cites this paper
• DRD2 Taq1A Polymorphism Modulates Prolactin Secretion Induced by Atypical Antipsychotics in Healthy Volunteers

  2011cites this paper
• Pharmacogenomics of antipsychotics efficacy for schizophrenia

  2011cites this paper
• Social participation reduces depressive symptoms among older adults: An 18-year longitudinal analysis in Taiwan

  2011cites this paper
• Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction

  2011cites this paper
• Dopamine D 2 receptor genetic variation and clinical response to antipsychotic drug treatment : A meta-analysis

  2010cites this paper
• Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.

  2010cites this paper
• D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.

  2010cites this paper
• Etude des facteurs cliniques et pharmacogénétiques prédictifs de la réponse (efficacité) aux traitements neuroleptiques atypiques dans la schizophrénie

  2009cites this paper
• Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research

  2009cites this paper
• The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.

  2007cites this paper
• Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment.

  2006cites this paper
• Association study of 12 polymorphisms spanning the dopamine D2 receptor gene and clozapine treatment response in two treatment refractory/intolerant populations

  2005cites this paper
• Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.

  2005cites this paper
• Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.

  2005cites this paper
• Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update.

  2004cites this paper
• Cognitive impairment: classification by 1H magnetic resonance spectroscopy

  2004cites this paper
• Reports on depressive symptoms in older adults with chronic conditions.

  2004cites this paper
• Overview: Towards individualized treatment in schizophrenia

  2003influential citation